This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Acambis Research Limited. Active years: 2011-2012.
Company Filing History:
Years Active: 2011-2012
Title: Michael James Darsley: Innovator in Bacterial Vaccines
Introduction
Michael James Darsley is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of microbiology, particularly in the development of bacterial vaccines. With a total of 3 patents to his name, Darsley is recognized for his innovative approaches to combating diarrheal diseases.
Latest Patents
Darsley's latest patents include groundbreaking inventions that focus on attenuated bacteria useful in vaccines. One of his notable inventions provides strains of bacteria, especially enterotoxigenic, which are attenuated by mutations in the genes encoding enterotoxins (LT, ST, EAST1). These strains can be further attenuated by the deletion of additional chromosomal genes. The invention also includes strains of attenuated bacteria that express immunogenic but non-toxic variants of one or more of these enterotoxins, making them useful as a vaccine against diarrheal disease. Another significant patent involves a bacterial cell that expresses three or more coli surface (CS) antigens, along with methods for creating such a cell. This cell is instrumental in developing vaccines against diarrhea.
Career Highlights
Darsley is currently associated with Acambis Research Limited, where he continues to advance his research in vaccine development. His work has been pivotal in addressing public health challenges related to bacterial infections.
Collaborations
Darsley has collaborated with esteemed colleagues, including Arthur Keith Turner and Judith Greenwood, to further enhance the impact of his research.
Conclusion
Michael James Darsley stands out as an influential inventor in the field of bacterial vaccines. His innovative patents and dedication to research contribute significantly to the fight against diarrheal diseases.